Our Region

Why Conduct Clinical Trials in Our Region?

Our region offers several advantages such as a desirable demographic, large population, low number of current clinical trials, prevalent Hispanic population, binational exposure into Mexico & Latin America, a growing healthcare market and sustainable infrastructure that can improve clinical trials diversity for the effective development of new medicines and therapies.

Patients for Recruitment

Given that 80% of trials fail to meet enrollment timelines due to increasingly complex protocols, and the difficulties finding patients meeting trial requirements, our region offers new opportunities to recruit patients effectively. Our region currently has a population of more than 2 million people. It’s the largest metropolitan area on the United States / Mexico border. The region is also the second largest bilingual, bi-national work force in the Western Hemisphere.

Clinical Trial Diversification

Today only 5% of patients participating in trials come from non-Caucasian populations. This estimate is well below the 35% needed to achieve adequate representation of minority populations.

Our region’s population can drive increased representation of Hispanic groups in clinical research. El Paso’s population is approximately 81% Hispanic and boasts many stable four-generation Hispanic families. New Mexico also has a large Hispanic population (68%) in addition to a large Native American population (11%). Ciudad Juarez’s population also offers a potential study group of Mexican and other Native groups. Over 81 percent of El Pasoans are Mexican American, and along with others of Latino background, comprise the fastest growing minority group in the country.